Not available outside of the UK & Ireland.
Biochem/physiol Actions
Peripheral dopamine receptor antagonist that does not cross the blood-brain barrier; anti-emetic.
Features and Benefits
This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
25, 100, 500 mg in poly bottle
This product has met the following criteria to qualify for the following awards: